Cargando…
MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway
Prostate cancer is still considered a significant health care challenge worldwide due in part to the distinct transformation of androgen‐dependent prostate cancer (ADPC) into treatment‐refractory castration‐resistant prostate cancer (CRPC). Consequently, there is an urgent need to explore novel mole...
Autores principales: | Guan, Han, You, Zonghao, Wang, Can, Fang, Fang, Peng, Rui, Mao, Likai, Xu, Bin, Chen, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488151/ https://www.ncbi.nlm.nih.gov/pubmed/30784214 http://dx.doi.org/10.1002/cam4.2029 |
Ejemplares similares
-
MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling
por: Guan, Han, et al.
Publicado: (2017) -
Coordinated AR and microRNA regulation in prostate cancer
por: Eringyte, Ieva, et al.
Publicado: (2020) -
MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma
por: Duan, Xiaohui, et al.
Publicado: (2020) -
microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer
por: Chen, Gen, et al.
Publicado: (2020) -
Human microRNA similarity in breast cancer
por: Jing, Ying, et al.
Publicado: (2021)